Only CXCL5 serum levels remained significantly increased in patients with more advanced vs. early HCC (CXCL5 ng/mL = 287 (14–2206) vs. 191 (82–1156), p = 0.049) (Figure 2A). The gene discussed is CXCL5; the disease is hepatocellular carcinoma.